New AI model identifies possible therapies from existing medicines for thousands of diseases, including rare ones with no current treatments.
The AI tool generates new insights on its own, applies them to conditions it was not trained for, and offers explanations for its predictions.
Tag: Orphan Diseases
Researchers Discover Test to Predict Which Patients with Rare Blood Disease Will Respond to Only FDA-Approved Treatment, and Identify Alternative Therapy
New research has uncovered a precision medicine test using blood proteins to identify a novel patient subgroup of idiopathic multicentric Castleman disease (iMCD), a rare blood disorder, who are more likely to respond to siltuximab, the only FDA approved treatment for the disease.